These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7294953)

  • 1. [Maternal treatment with indomethacin and severe neonatal pulmonary hypertension (author's transl)].
    Dalens B; Dechelotte P; Gaulme J; Raynaud EJ
    Arch Fr Pediatr; 1981 Apr; 38(4):261-5. PubMed ID: 7294953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent pulmonary hypertension in the newborn caused by prenatal use of prostaglandin inhibitors, (indomethacin). Report of a case].
    Lozano González CH; Galindo Jiménez P; Pezzotti MA; Lowenberg Favela E
    Ginecol Obstet Mex; 1980 Aug; 48(286):103-10. PubMed ID: 7450523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fetal hydrops following indomethacin administration during pregnancy].
    Verboom AJ; de Leeuw R
    Ned Tijdschr Geneeskd; 1983 Jan; 127(1):18-20. PubMed ID: 6828168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostaglandin and threat of premature labour inhibitors. 1. The possibilities and consequences (as given in the literature) (author's transl)].
    Maria B
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(6):721-5. PubMed ID: 7462576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistance of fetal circulation. a case associated to maternal indomethacin administration (author's transl)].
    Molina V; Krauel J; Baraibar R; Campistol J
    An Esp Pediatr; 1980 Feb; 13(2):162-8. PubMed ID: 7396272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor.
    Butler-O'Hara M; D'Angio CT
    J Perinatol; 2002; 22(7):541-6. PubMed ID: 12368969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indomethacin in threatening premature labor. Fetal and neonatal cardiovascular effects].
    Díaz-Calderon O; Velazco-Olivares M; Danglot-Banck C; Gómez-Gomez M; Covarrubias-Villegas R
    Ginecol Obstet Mex; 1992 Dec; 60():326-30. PubMed ID: 1478511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maternal administration of indomethacin and neonatal tricuspid insufficiency].
    Magny JF; Petit J; Saby MA; Dehan M; Gabilan JC
    Arch Fr Pediatr; 1987 Mar; 44(3):189-90. PubMed ID: 3579483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maternal and neonatal effects of indomethacin administrated during pregnancy. Apropos of 18 cases].
    Jacqz-Aigrain E; Guillonneau M; Boissinot C; Bavoux F; Hartmann JF; Blot P
    Arch Fr Pediatr; 1993 Apr; 50(4):307-12. PubMed ID: 8379817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn.
    Manchester D; Margolis HS; Sheldon RE
    Am J Obstet Gynecol; 1976 Oct; 126(4):467-9. PubMed ID: 985646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine and indomethacin: fetal anuria, neonatal edema, and gastrointestinal bleeding.
    Carlan SJ; Stromquist C; Angel JL; Harris M; O'Brien WF
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):501-3. PubMed ID: 1870807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligohydramnios induced by maternal indomethacin therapy.
    Uslu T; Ozcan FS; Aydin C
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):230-2. PubMed ID: 1506126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indomethacin and a tocolytic agent: fetal and neonatal outcome].
    Shamir R; Litwin A; Merlob A
    Harefuah; 1990 Dec; 119(11):387-90. PubMed ID: 2289720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Twin pregnancy, indomethacin and neonatal cyanosis (author's transl)].
    Boulley AM; Dehan M; Vial M; Hernandorena X; Ropert JC; Laudignon N; Lhermitte C; Gabilan JC
    Arch Fr Pediatr; 1980 May; 37(5):317-9. PubMed ID: 7469707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn.
    Turner GR; Levin DL
    Clin Perinatol; 1984 Oct; 11(3):581-9. PubMed ID: 6488671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.
    Gloor JM; Muchant DG; Norling LL
    J Perinatol; 1993; 13(6):425-7. PubMed ID: 8308583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of premature labor with indomethacin and its effect on the fetus].
    Sturc M; Turek J; Wawreczka K
    Cesk Gynekol; 1982 Dec; 47(10):751-3. PubMed ID: 7159946
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome.
    Csaba IF; Sulyok E; Ertl T
    J Pediatr; 1978 Mar; 92(3):484. PubMed ID: 632996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.